Core Insights - The company's net profit attributable to shareholders increased by 27.5% to HKD 7.709 billion, but profit from recurring operations declined by 15.7% to HKD 3.391 billion, indicating a shift in the profit structure with property development becoming the main driver of overall performance [1] Financing and Investment - The company conducted two large-scale public financings in the first half of 2025, raising a total of USD 6 billion to support its infrastructure investment plans, including a record USD 3 billion bond issuance in March [3] - The funds raised will support approximately HKD 140 billion in new railway projects and HKD 65 billion for railway facility updates and maintenance from 2023 to 2027 [3] New Railway Projects - The company made significant progress in new railway projects, signing an agreement with the government for the Northern Link (Phase 1) project, which will enhance connectivity between Hong Kong and Shenzhen [4] - The company plans to open the main line and branch line of the Northern Link by 2034, reflecting its commitment to government policies and innovative thinking [4] - Ongoing construction projects include various extensions and new stations, but the company faces challenges in managing construction impacts on existing operations and communities [4] Operational Performance - The company maintained a high service level with a 99.9% punctuality rate in passenger journeys during the first half of 2025, and ticket prices will remain unchanged for the 2025/2026 fiscal year [6] - The property development segment contributed significantly to profit growth, with ongoing projects expected to provide around 9,000 residential units [6] - However, the company faces multiple challenges, including geopolitical uncertainties, inflation, and changing passenger behaviors post-COVID-19, which may affect ridership and advertising revenue [6]

消息面上，港铁公司公布中期业绩，上半年收入为273.6亿港元，同比下跌6.5%；纯利77.09亿港元，同 比增长27.5%；每股盈利1.24港元。中期息每股42港仙，与去年同期持平。 公告显示，期内来自经常性业务的利润约33.91亿元，下跌15.7%，期内物业发展利润按年增加218.5%至 55.42亿元，主要来自何文田站第一期和第二期项目及"港岛南岸"第三期和第五期项目的贡献，基本业 务利润增长近55%至89.33亿元；港铁期内录得投资物业公允价值计量亏损12.24亿元，对比去年同期录 收益2.8亿元。 智通财经APP获悉，港铁公司(00066)绩后跌超5%，截至发稿，跌4.59%，报27.04港元，成交额8582.19 万港元。 ...

Group 1: Core Insights - Rongchang Biologics (09995.HK) announced that its innovative drug Taitasip (brand name: Tai Ai®) for treating primary Sjögren's syndrome has met the primary endpoint in a Phase III clinical trial in China [1] - Taitasip is the first BLyS/APRIL dual-target fusion protein drug to complete Phase III research in the field of Sjögren's syndrome globally [1] - The clinical trial was a multi-center, randomized, double-blind, placebo-controlled study aimed at evaluating the efficacy and safety of Taitasip, with the primary endpoint being the change in ESSDAI score at week 24 compared to baseline [1] Group 2: Disease Background and Drug Mechanism - Sjögren's syndrome is a chronic inflammatory autoimmune disease characterized by lymphocytic infiltration and damage to exocrine glands, leading to persistent dry mouth and dry eyes, and can affect multiple organ systems [2] - The prevalence of Sjögren's syndrome in China is estimated to be between 0.3% and 0.7%, with an increasing trend indicating a significant unmet clinical need [2] - Taitasip is a novel dual-target fusion protein developed by the company that simultaneously inhibits the overexpression of BLyS and APRIL, effectively preventing abnormal differentiation and maturation of B cells [2] Group 3: Regulatory and Clinical Recognition - Taitasip has received multiple authoritative guideline recommendations in China, including the "Clinical Practice Guidelines for Sjögren's Syndrome" and the "Expert Consensus on B-cell Targeted Therapy for Rheumatic and Immune Diseases" [2] - Internationally, Taitasip has been granted Fast Track designation by the U.S. FDA for its indication in Sjögren's syndrome and has been approved to conduct global multi-center Phase III clinical trials [2]

中新社香港8月14日电 (记者 韩星童)香港铁路有限公司(简称"港铁")14日公布，今年上半年录得77.09亿 元(港元，下同)的净利润，同比上升27.5%。 期内，来自全香港车站商务活动的总收入同比减少0.6%至26.21亿元，主要因为广告及电讯业务收入下 跌；车站零售租金收入同比增加2.6%至18.34亿元，主要因为免税店的租金收入上升；香港物业管理业 务收入同比增加9.8%至1.57亿元，物业发展利润同比上升约2.2倍至约55.4亿元。 港铁行政总裁金泽培表示，今年上半年，港铁在不断拓展的新铁路项目方面迈出重要步伐，同时乘客量 稳步攀升，为公司带来稳健的营运收入。 展望未来，金泽培指出，港铁期望通过《铁路发展策略2014》及《香港主要运输基建发展蓝图》下多个 项目延续佳绩，为特区政府的新发展计划提供支持，在香港打造世界级的铁路项目。此外，港铁将继续 在中国内地及海外寻求拓展港铁和香港品牌的发展机会。(完) 据公布的数据显示，港铁上半年总收入同比下降6.5%至273.6亿元。来自经常性业务的股东应占利润为 33.91亿元，同比下降15.7%。 今年上半年，港铁香港车务营运收入为115.09亿元，同比上升3 ...

Group 1 - The company, MTR Corporation (00066), announced that it will distribute an interim dividend of HKD 0.42 per share for the six months ending June 30, 2025 [1]

智通财经APP讯，港铁公司(00066)发布公告，该公司将于2025年9月16日派发截至2025年6月30日止6个 月的中期股息每股0.42港元。 ...

Group 1: Financial Performance - The company reported total revenue of HKD 27.36 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 6.5% [1] - Shareholders' profit attributable to the company was HKD 7.709 billion, showing a year-on-year increase of 27.5% [1] - Earnings per share were HKD 1.24, with an interim ordinary dividend declared at HKD 0.42 per share [1] Group 2: Hong Kong Operations - The increase in passenger volume for transit and high-speed rail services contributed to stable revenue growth in Hong Kong operations [2] - The heavy rail network maintained a world-class punctuality level of 99.9% for scheduled train services [2] - Profit from property development in Hong Kong was HKD 5.5 billion, primarily from projects at Ho Man Tin Station and the South Island Line [2] - A project agreement has been signed with the government for the first section of the Northern Link [2] Group 3: Mainland China and International Operations - The company continues to advance construction on the Sydney Metro M1 Northwest and Bankstown Line Southwest, as well as other sections of Shenzhen Metro Line 13 and the mid-section of Beijing Metro Line 17 [3] - The operational rights for the UK Elizabeth Line and South Western Railway will be transferred to the next operator by May 2025 [3] - The company is developing station businesses in Chengdu, Zhengzhou, and Xi'an [3]

格隆汇8月14日丨港铁公司(00066.HK)公布中期业绩，截至2025年6月30日止六个月，集团总收入273.60 亿港元，同比减少6.53%；公司股东应占期内利润为77.09亿港元，同比增长27.55%，基本每股盈利1.24 港元，宣派中期普通股息每股0.42港元。 2025年上半年，来自经常性业务的股东应占利润为33.91亿港元，去年同期为40.24亿港元，主要因为来 自香港业务的贡献受经营开支上升影响而有所减少。受惠于集团早前开展的物业发展项目于此段期间取 得成果，回顾期内物业发展利润增加至55.42亿港元，因此来自基本业务的利润增加55.0%至89.33亿港 元。若包括投资物业公允价值计量所产生的亏损(此为非现金会计项目)12.24亿港元，公司股东应占净利 润增加27.5%至77.09亿港元，相当于每股盈利1.24港元。 ...

Core Viewpoint - The MTR Corporation reported a total revenue of HKD 27.36 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 6.5%, while shareholder profit increased by 27.5% to HKD 7.709 billion, with earnings per share at HKD 1.24 and an interim dividend of HKD 0.42 per share [1] Hong Kong Operations - The increase in passenger volume for the cross-border and high-speed rail services contributed to steady revenue growth in Hong Kong's railway operations [2] - The heavy rail network maintained a world-class punctuality level of 99.9% for scheduled train services [2] - Profit from property development in Hong Kong reached HKD 5 billion, primarily from projects at Ho Man Tin Station and the third and fifth phases of the "Southern Island" project [2] - A project agreement has been signed with the government for the first section of the Northern Link [2] Mainland China and International Operations - The company continues to advance construction on the Sydney Metro M1 Northwest and Bankstown Line Southwest, as well as additional sections of Shenzhen Metro Line 13 and the mid-section of Beijing Metro Line 17 [3] - The operational rights for the UK Elizabeth Line and South Western Railway were transferred to the next operator in May 2025 [3] - The company is currently developing station businesses in Chengdu, Zhengzhou, and Xi'an [3]

第 1 頁 共 2 頁 v 1.1.1 發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 董事局: 歐陽伯權博士(主席)**、金澤培博士(行政總裁)、包立賢*、陳振彬博士*、鄭恩基*、許少偉*、劉麥嘉軒*、李惠光*、吳永 嘉*、孫淑貞* 、唐家成博士*、黃幸怡*、黃冠文*、黃慧群教授*、許正宇(財經事務及庫務局局長)**、運輸及物流局局長(陳美 寶)**、發展局常任秘書長(工務)(劉俊傑)**及運輸署署長(李頌恩)** 執行總監會: 金澤培博士、楊美珍 、鄭惠貞、蔡少綿、鄧輝豪、樊米高、馬琳、鄧智輝及黃琨暐 * 獨立非執行董事 ** 非執行董事 EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 香港鐵路有限公司 | | 股份代號 | 00066 | | 多櫃檯股份代 ...